These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 30071883

  • 1. Body iron status of children and adolescents with transfusion dependent β-thalassaemia: trends of serum ferritin and associations of optimal body iron control.
    Suriapperuma T, Peiris R, Mettananda C, Premawardhena A, Mettananda S.
    BMC Res Notes; 2018 Aug 02; 11(1):547. PubMed ID: 30071883
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of deferasirox in multitransfused Indian children with β-thalassaemia major.
    Chandra J, Chaudhary H, Pemde H, Singh V, Dutta AK.
    Ann Trop Paediatr; 2011 Aug 02; 31(1):47-51. PubMed ID: 21262109
    [Abstract] [Full Text] [Related]

  • 3. Thyroid function in thalassaemia major.
    Senanayake MP, Suraweera SA, Hubert HD.
    Ceylon Med J; 1999 Dec 02; 44(4):166-8. PubMed ID: 10895267
    [Abstract] [Full Text] [Related]

  • 4. Use of Iron Chelating Agents in Transfusion Dependent Thalassaemia Major Patients.
    Santra S, Bhattacharya A, Mukhopadhyay T, Agrawal D, Kumar S, Das P, Chakrabarty P.
    Mymensingh Med J; 2015 Oct 02; 24(4):838-44. PubMed ID: 26620028
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study.
    Premawardhena AP, Ediriweera DS, Sabouhanian A, Allen A, Rees D, de Silva S, Perera W, Katugaha N, Arambepola M, Yamashita RC, Mettananda S, Jiffry N, Mehta V, Cader R, Bandara D, St Pierre T, Muraca G, Fisher C, Kirubarajan A, Khan S, Allen S, Lamabadusuriya SP, Weatherall DJ, Olivieri NF.
    Lancet Glob Health; 2022 Jan 02; 10(1):e134-e141. PubMed ID: 34843671
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and Tolerability of Twice-Daily Dosing Schedule of Deferasirox in Transfusion-Dependent Paediatric Beta-Thalassaemia Patients: A Randomized Controlled Study.
    Panachiyil GM, Babu T, Sebastian J, Ravi MD.
    J Pharm Pract; 2023 Aug 02; 36(4):749-755. PubMed ID: 35473439
    [Abstract] [Full Text] [Related]

  • 8. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR, De Sanctis V, Gilli G.
    Pediatr Endocrinol Rev; 2008 Oct 02; 6 Suppl 1():158-69. PubMed ID: 19337172
    [Abstract] [Full Text] [Related]

  • 9. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
    Belhoul KM, Bakir ML, Saned MS, Kadhim AM, Musallam KM, Taher AT.
    Ann Hematol; 2012 Jul 02; 91(7):1107-14. PubMed ID: 22281991
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major.
    Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B.
    Br J Haematol; 2000 Sep 02; 110(4):971-7. PubMed ID: 11054091
    [Abstract] [Full Text] [Related]

  • 13. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study.
    Soliman AT, elZalabany M, Amer M, Ansari BM.
    J Trop Pediatr; 1999 Feb 02; 45(1):23-30. PubMed ID: 10191589
    [Abstract] [Full Text] [Related]

  • 14. Anaemia among females in child-bearing age: Relative contributions, effects and interactions of α- and β-thalassaemia.
    Mettananda S, Suranjan M, Fernando R, Dias T, Mettananda C, Rodrigo R, Perera L, Gibbons R, Premawardhena A, Higgs D.
    PLoS One; 2018 Feb 02; 13(11):e0206928. PubMed ID: 30388173
    [Abstract] [Full Text] [Related]

  • 15. Thyroid Status in Children with Transfusion Dependent Hb-E β-Thalassaemia.
    Sharmin T, Mollah AH, Morshed AA, Chowdhury MK.
    Mymensingh Med J; 2018 Apr 02; 27(2):348-357. PubMed ID: 29769501
    [Abstract] [Full Text] [Related]

  • 16. Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy.
    Sharma R, Seth A, Chandra J, Gohain S, Kapoor S, Singh P, Pemde H.
    Paediatr Int Child Health; 2016 Feb 02; 36(1):22-7. PubMed ID: 25311879
    [Abstract] [Full Text] [Related]

  • 17. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S, Pathare AV.
    Ann Hematol; 2006 May 02; 85(5):315-9. PubMed ID: 16450126
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of Deferasirox (Exjade®) in Modulation of Iron Overload in Patients with β-Thalassemia Intermedia.
    Karimi M, Arandi N, Haghpanah S, Ansari S, Azarkeyvan A, Bordbar M, Safaei S.
    Hemoglobin; 2015 May 02; 39(5):327-9. PubMed ID: 26114738
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.